Psychological factors including the perception of the couple relationship appeared prominent in BCS women's experience of sexual problems.

We conducted a cross-sectional study of 156 ambulatory HIV-infected homosexual or bisexual men to assess and compare the prevalence and characteristics of sexual dysfunction according to treatment combinations (group A, protease inhibitor [PI] treatment; group B, no PI treatment; and C, PI treatment interrupted >1 month previously). The study was based on a self-administered 163-item questionnaire that included a French translation of the International Index of Erectile Function, five sections of the Derogatis Sexual Functioning Inventory, and open questions. Data analysis was performed using Mann-Whitney and Kruskal-Wallis H nonparametric tests (quantitative values) and chi2 tests (qualitative values) using SPSS software (SPSS, Chicago, IL, U.S.A.). One hundred fifty-six patients completed the study. The median age +/- SD of the patients was 40.5 +/- 7.7 years, and the median CD4+ cell count +/- SD was 415 +/- 236/mm3. One hundred eleven (71%) of 156 patients reported some degree of sexual dysfunction since the beginning of their treatment (65 [71%] of 91 group A patients; 15 [65%] of 23 group B patients; and 31 [74%] of 42 group C patients), with no significant difference among the groups. Of the 111 patients, 99 (89%) reported decrease or loss of libido, 76 (68%) reported orgasmic perturbation, 96 (86%) reported erectile dysfunction, and 65 (59%) reported ejaculation perturbation, with no significant difference among the three groups. There were no significant differences among the three groups regarding the International Index of Erectile Function and Derogatis Sexual Functioning Inventory scores. These data suggest that PI-based therapy does not seem to increase sexual dysfunction in this patient population.

No abstract

The World Health Organization is developing the 11th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-11), planned for publication in 2017. The Working Group on the Classification of Sexual Disorders and Sexual Health was charged with reviewing and making recommendations on disease categories related to sexuality in the chapter on mental and behavioural disorders in the 10th revision (ICD-10), published in 1990. This chapter includes categories for diagnoses based primarily on sexual orientation even though ICD-10 states that sexual orientation alone is not a disorder. This article reviews the scientific evidence and clinical rationale for continuing to include these categories in the ICD. A review of the evidence published since 1990 found little scientific interest in these categories. In addition, the Working Group found no evidence that they are clinically useful: they neither contribute to health service delivery or treatment selection nor provide essential information for public health surveillance. Moreover, use of these categories may create unnecessary harm by delaying accurate diagnosis and treatment. The Working Group recommends that these categories be deleted entirely from ICD-11. Health concerns related to sexual orientation can be better addressed using other ICD categories.

Objectiveto comprehend the psychosocial and cultural repercussions of breast cancer and its treatment on the sexuality of women.Methodthis is a qualitative study grounded in the Sexual Scripts Theory with the participation of 23 women who were interviewed and participated in focus groups discussion.Resultseach category was related to a level of the sexual scripts. At the cultural scenario level a discourse on sexuality that includes definitions of sexual attractiveness and sexuality was highlighted. The interpersonal scripts level focused on the communication regarding sexuality established with the partner and with healthcare professionals category; and at the subjectivity scripts level the reports of improvement, deterioration and no change in the sexual life after cancer were analyzed.Conclusionthe experience of cancer involves cultural, relational, and subjective aspects that affect the sexual life, therefore, healthcare professionals should be aware of them to improve integral healthcare.

As terapias de reposição hormonal assim como as novas moléculas (sildenafil, tadalafil) que lutam contra as disfunções da ereção revelaram a demanda crescente na área da saúde sexual na segunda metade da vida. Entretanto, o lugar da sexualidade no processo de envelhecimento constitui um assunto particularmente contaminado por preconceitos. A complementaridade entre a teoria sociológica e a teoria psicanalítica permite esclarecer a dupla natureza deste fenômeno, em que o recalcamento intrapsíquico é fruto, em primeiro lugar, dos ideais culturais interiorizados. Com o propósito de uma comparação transcultural, procedeu-se à aplicação de um questionário amplo a duas amostras, uma brasileira e outra portuguesa, de maneira a caracterizar conhecimentos, atitudes, crenças e práticas sobre a vivência do corpo e da sexualidade de 187 pessoas entre 52 e 90 anos gozando de boa saúde física e mental.

Algumas definições de transexualidade incluem a questão da cirurgia de redesignação sexual como um desejo inerente aos(às) transexuais. Este estudo teve por objetivo investigar os significados atribuídos à cirurgia por quatro mulheres transexuais, destacando as concepções a respeito das mudanças que a redesignação acarreta na vida da pessoa transexual. Os dados foram colhidos mediante aplicação individual de entrevista aberta na modalidade história de vida temática. O material transcrito foi organizado sob a forma de estudos de caso e analisado com base na Teoria Queer. Os resultados sugerem que os significados atribuídos à cirurgia são polissêmicos e mutáveis ao longo do processo de desenvolvimento e que o desejo de se submeter ao procedimento não deve ser um critério definidor da transexualidade.

Drawing from controversies between medical, legal, and associative actors about the obligation of sex reassignment surgeries (SRS) for people who intend to change their civil status, this article discusses the role that medical procedures, and particularly SRS, play in contemporary gender identifications and transition pathways in France. In 2010, the French National Institute of Health and Medical Research conducted a national survey in order to study the sociodemographic characteristics, access to medical, and psychological care, and state of health among trans individuals. After a long period of ethnographic work during which a partnership was established with trans actors to map the social, medical, and political landscape of trans communities, a questionnaire was developed and distributed between July and October 2010 in collaboration with most of the trans organizations and public and private health professionals operating in France. Overall, 381 self-identified trans individuals returned the anonymous self-administered questionnaire. The results highlighted the heterogeneity of the trans population, whose definition cannot be reduced to a group of individuals undergoing standardized hormonal treatments and SRS. Two central indicators, sex assigned at birth and gender self-identification, enabled us to describe and analyze different medical and legal pathways with a particular focus on SRS, which is often compulsory for a change of civil status in France. Although SRS remains an important factor in an individual's subjective evaluation of the success of the transition pathway, its practice varies depending on one's sex assigned at birth and gender identification.